Posts

Ochsner Health selects DeepScribe to bring ambient AI t...

New Orleans, LA – July 30, 2024 – Ochsner Health announces an enterprise-wide ag...

New collaborative research generates lessons for more a...

“Sometimes the crazy ideas lead to watershed improvements.” Credit: USU/Matt Jen...

Innovative tissue analysis: Pioneering controllable his...

In a pioneering development for the biomedical field, a research team led by Yua...

Enhancing power system stability: Tianjin University un...

Fast and accurate transient stability analysis is crucial to power system operat...

Ammonia-free gallium nitride semiconductor production i...

Gallium nitride (GaN) semiconductors can now be grown without ammonia, a toxic c...

Breakthrough in high-performance computing and quantum ...

Led by University of Melbourne theoretician and HPC expert Associate Professor G...

Invasive insect herbivore alters ecosystem services del...

A study published in the June 2024 issue of the journal Pedosphere looks at how ...

Newly discovered sheets of nanoscale “cubes” make excel...

Tokyo, Japan – Researchers from Tokyo Metropolitan University have created sheet...

Keck Hospital of USC earns five stars on CMS 2024 quali...

LOS ANGELES — Keck Hospital of USC earned five stars, the highest rating possibl...

Edwards acquires 2 firms in deals totaling $1.2 billion

The acquisitions by Edwards of JenaValve Technology and Endotronics come as the ...

Europe risks a setback for Eisai and Biogen’s Alzheimer...

Regulatory authorities in the European Union have declined to approve Eisai and ...

Ventyx’s Crohn’s Disease Medicine Fails to Make a Mark ...

In a phase 2 experiment, the Crohn’s disease medication developed by Ventyx Bios...

EU CHMP snubs Biogen and Eisai’s Alzheimer’s therapy Le...

The European agency said that Leqembi’s efficacy was “not large enough” to outwe...

Attralus set for amyloidosis asset’s European orphan de...

EMA’s COMP has adopted positive opinions for two orphan medicinal product design...

EC approves measure to produce radioisotopes for cancer

The European Commission (EC) has granted approval to a €2bn Dutch measure to pro...

FDA approves Luye Pharma’s ERZOFRI for schizophrenia

The US FDA has granted approval for Luye Pharma’s ERZOFRI extended-release injec...